Correlation Between MaxCyte and NAYA Biosciences,

Can any of the company-specific risk be diversified away by investing in both MaxCyte and NAYA Biosciences, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and NAYA Biosciences, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between MaxCyte and NAYA Biosciences,, you can compare the effects of market volatilities on MaxCyte and NAYA Biosciences, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of NAYA Biosciences,. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and NAYA Biosciences,.

Diversification Opportunities for MaxCyte and NAYA Biosciences,

0.56

Correlation Coefficient

MaxCyte  NAYA Biosciences,

Very weak diversification

The 3 months correlation between MaxCyte and NAYA is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and NAYA Biosciences, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAYA Biosciences, and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with NAYA Biosciences,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAYA Biosciences, has no effect on the direction of MaxCyte i.e., MaxCyte and NAYA Biosciences, go up and down completely randomly.

Pair Corralation between MaxCyte and NAYA Biosciences,

Given the investment horizon of 90 days MaxCyte is expected to generate 0.42 times more return on investment than NAYA Biosciences,. However, MaxCyte is 2.36 times less risky than NAYA Biosciences,. It trades about -0.15 of its potential returns per unit of risk. NAYA Biosciences, is currently generating about -0.22 per unit of risk. If you would invest  413.00  in MaxCyte on December 27, 2024 and sell it today you would lose (131.50) from holding MaxCyte or give up 31.84% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

MaxCyte  vs.  NAYA Biosciences,

MaxCyte

Risk-Adjusted Performance

Very Weak

Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

NAYA Biosciences,

Risk-Adjusted Performance

Very Weak

Over the last 90 days NAYA Biosciences, has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with MaxCyte and NAYA Biosciences,

The main advantage of trading using opposite MaxCyte and NAYA Biosciences, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, NAYA Biosciences, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NAYA Biosciences, will offset losses from the drop in NAYA Biosciences,'s long position.

The idea behind MaxCyte and NAYA Biosciences, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.